HPV-16 E5 oncoprotein upregulates lipid raft components caveolin-1 and ganglioside GM1 at the plasma membrane of cervical cells (Oncogene (2008) 27, (1071-1078) DOI: 10.1038/sj.onc.1210725);HPV-16 E5 oncoprotein upregulates lipid raft components caveolin-1 and ganglioside GM1 at the plasma membrane of cervical cells

Oncogene

Volumn 27, Issue 8, 2008, Pages 1071-1078

  Suprynowicz, F A ^a   Disbrow, G L ^a   Krawczyk, E ^a   Simic, V ^a   Lantzky, K ^a   Schlegel, R ^a  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Caveolin 1; Ganglioside GM1; HPV 16 E5 oncoprotein

Indexed keywords

CAVEOLIN 1; EPIDERMAL GROWTH FACTOR RECEPTOR; GANGLIOSIDE GM1; ONCOPROTEIN; ONCOPROTEIN E5; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CELL MEMBRANE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; LIPID RAFT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; UTERINE CERVIX CANCER;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; PAPILLOMAVIRIDAE;

EID: 39149119222     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2008.357     Document Type: Erratum

References (40)

1. Ashrafi GH, Haghshenas M, Marchetti B, Campo MS. (2006). E5 protein of human papillomavirus 16 downregulates HLA class I and interacts with the heavy chain via its first hydrophobic domain. Int J Cancer 119: 2105-2112.
2. Bacia K, Scherfeld D, Kahya N, Schwille P. (2004). Fluorescence correlation spectroscopy relates rafts in model and native membranes. Biophys J 87: 1034-1043.
3. Baege AC, Berger A, Schlegel R, Veldman T, Schlegel R. (2002). Cervical epithelial cells transduced with the papillomavirus E6/E7 oncogenes maintain stable levels of oncoprotein expression but exhibit progressive, major increases in hTERT gene expression and telomerase activity. Am J Pathol 160: 1251-1257.
4. Bravo IG, Crusius K, Alonso A. (2005). The E5 protein of the human papillomavirus type 16 modulates composition and dynamics of membrane lipids in keratinocytes. Arch Virol 150: 231-246.
5. Brown DA, London E. (1998). Functions of lipid rafts in biological membranes. Annu Rev Cell Dev Biol 14: 111-136.
6. Cebo C, Da Rocha S, Wittnebel S, Turhan AG, Abdelali J, Caillat-Zucman S et al. (2006). The decreased susceptibility of Bcr/Abl targets to NK cell-mediated lysis in response to imatinib mesylate involves modulation of NKG2D ligands, GM1 expression and synapse formation. J Immunol 176: 864-872.
7. Chamberlain LH. (2004). Detergents as tools for the purification and classification of lipid rafts. FEBS Lett 559: 1-5.
8. Clifford GM, Smith JS, Plummer M, Munoz N, Franceschi S. (2003). Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer 88: 63-73.
9. Conrad M, Bubb VJ, Schlegel R. (1993). The human papillomavirus type 6 and 16 E5 proteins are membrane-associated proteins which associate with the 16-kilodalton pore-formingprotein. J Virol 67: 6170-6178.
10. Davis DM, Dustin ML. (2004). What is the importance of the immunological synapse? Trends Immunol 25: 323-327.
11. Denker SP, McCaffery JM, Palade GE, Insel PA, Farquhar MG. (1996). Differential distribution of α subunits and βγ subunits of heterotrimeric G proteins on Golgi membranes of the exocrine pancreas. J Cell Biol 133: 1027-1040.
12. Disbrow GL, Hanover JA, Schlegel R. (2005). Endoplasmic reticulum-localized human papillomavirus type 16 E5 protein alters endosomal pH but not trans-Golgi pH. J Virol 79: 5839-5846.
13. Disbrow GL, Sunitha I, Baker CC, Hanover J, Schlegel R. (2003). Codon optimization of the HPV-16 E5 gene enhances protein expression. Virology 311: 105-114.
14. Fehrmann F, Laimins LA. (2003). Human papillomaviruses: targeting differentiating cells for malignant transformation. Oncogene 22: 5201-5207.
15. Fra AM, Masserini M, Palestini P, Sonnino S, Simons K. (1995). A photo-reactive derivative of ganglioside GM1 specifically cross-links VIP21-caveolin on the cell surface. FEBS Lett 375: 11-14.
16. Frazer IH. (1996). Immunology of papillomavirus infection. Curr Opin Immunol 8: 484-491.
17. Genther-Williams SM, Disbrow GL, Schlegel R, Lee D, Threadgill DW, Lambert PF. (2005). Requirement of epidermal growth factor receptor for hyperplasia induced by E5, a high-risk human papillomavirus oncogene. Cancer Res 65: 6534-6542.
18. Grakoui A, Bromley SK, Sumen C, Davis MM, Shaw AS, Allen PM et al. (1999). The immunological synapse: a molecular machine controlling T cell activation. Science 285: 221-227.
19. Hansson GC, Simons K, van Meer G. (1986). Two strains of the Madin Darby canine kidney (MDCK) cell line have distinct glycosphingolipid compositions. EMBO J 5: 483-489.
20. Hao M, Mukherjee S, Sun Y, Maxfield FR. (2004). Effects of cholesterol depletion and increased lipid unsaturation on the properties of endocytic membranes. J Biol Chem 279: 14171-14178.
21. McKallip R, Li R, Ladisch S. (1999). Tumor gangliosides inhibit the tumor-specific immune response. J Immunol 163: 3718-3726.
22. Mundy DI, Machleidt T, Ying Y, Anderson RGW, Bloom GS. (2002). Dual control of caveolar membrane traffic by microtubules and the actin cytoskeleton. J Cell Sci 115: 4327-4339.
23. Nishio M, Tajima O, Furukawa K, Urano T, Furukawa K. (2005). Over-expression of GM1 enhances cell proliferation with epidermal growth factor without affecting the receptor localization in the microdomain in PC12 cells. Int J Oncol 26: 191-199.
24. O'Brien PM, Campo MS. (2002). Evasion of host immunity directed by papillomavirus-encoded proteins. Virus Res 88: 103-117.
25. Parton RG. (1994). Ultrastructural localization of gangliosides; GM1 is concentrated in caveolae. J Histochem Cytochem 42: 155-166.
26. Razani B, Woodman SE, Lisanti MP. (2002). Caveolae: from cell biology to animal physiology. Pharmacol Rev 54: 431-467.
27. Riley RR, Duensing S, Brake T, Munger K, Lambert PF, Arbeit JM. (2003). Dissection of human papillomavirus E6 and E7 function in transgenic mouse models of cervical carcinogenesis. Cancer Res 63: 4862-4871.
28. +-ATPase can be dissociated from the E5-mediated epidermal growth factor receptor overactivation. Oncogene 19: 3727-3732.
29. Schiffman M, Herrero R, Desalle R, Hildesheim A, Wacholder S, Rodriguez AC et al. (2005). The carcinogenicity of human papillomavirus types reflects viral evolution. Virology 337: 76-84.
30. Shurin GV, Shurin MR, Bykovskaia S, Shogan J, Lotze MT, Barksdale EM. (2001). Neuroblastoma-derived gangliosides inhibit dendritic cell generation and function. Cancer Res 61: 363-369.
31. Skibbens JE, Roth MG, Matlin KS. (1989). Differential extractability of influenza virus hemagglutinin during intracellular transport in polarized epithelial cells and nonpolar fibroblasts. J Cell Biol 108: 821-832.
32. Sotgia F, Razani B, Bonuccelli G, Schubert W, Battista M, Lee H et al. (2002). Intracellular retention of glycosylphosphatidyl inositol-linked proteins in caveolin-deficient cells. Mol Cell Biol 22: 3905-3926.
33. Stuermer CA, Lang DM, Kirsch F, Wiechers M, Deininger SO, Plattner H. (2001). Glycosylphosphatidyl inositol-anchored proteins and fyn kinase assemble in noncaveolar plasma membrane microdomains defined by reggie-1 and -2. Mol Biol Cell 12: 3031-3045.
34. Suprynowicz FA, Campo MS, Schlegel R. (2006). Biological activities of papillomavirus E5 proteins. In: Campo MS (ed). Papillomavirus Research: From Natural History to Vaccines and Beyond. Caister Academic Press: Wymondham, UK, pp 97-113.
35. Suprynowicz FA, Disbrow GL, Simic V, Schlegel R. (2005). Are transformingproperties of the bovine papillomavirus E5 protein shared by E5 from high-risk human papillomavirus type 16? Virology 332: 102-113.
36. Thomsen P, Roepstorff K, Stahlhut M, van Deurs B. (2002). Caveolae are highly immobile plasma membrane microdomains, which are not involved in constitutive endocytic trafficking. Mol Biol Cell 13: 238-250.
37. Thomsen P, van Deurs B, Norrild B, Kayser L. (2000). The HPV-16 E5 oncogene inhibits endocytic trafficking. Oncogene 19: 6023-6032.
38. van Meer G. (1989). Lipid traffic in animal cells. Annu Rev Cell Biol 5: 247-275.
39. Vyas YM, Maniar H, Dupont B. (2002). Visualization of signaling pathways and cortical cytoskeleton in cytolytic and noncytolytic natural killer cell immune synapses. Immunol Rev 189: 161-178.
40. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV et al. (1999). Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189: 12-19.